Skip to main content

Table 2 Blood levels of MUC1 and VEGF mRNA in NSCLC patients and BLD patients at two sampling time points

From: Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer

Patient N MUC1 mRNA VEGF mRNA
B0 B4w P value B0 B4w P value
Median Range Median Range Median Range Median Range
NSCLC 66 5.95 1.16-17.56 4.46 0.64-12.45 0.027 4.88 1.07-15.32 3.82 0.88-13.84 0.035
BLD 55 2.06 0.32-4.17     1.75 0.41-3.28    
P value   <0.001   0.002*    <0.001   0.003*   
  1. *NSCLC patients at B4w compared with BLD patients.
\